Sign Up to like & get
recommendations!
0
Published in 2021 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfab094.0020
Abstract: The use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) is associated with increase of hemoglobin (Hb) levels and this effect has been related to improvement of tubulointerstitial hypoxia and increase on EPO production. Chronic kidney disease…
read more here.
Keywords:
cotransporter inhibitors;
estimated glomerular;
sodium glucose;
increase ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Indian Journal of Endocrinology and Metabolism"
DOI: 10.4103/ijem.ijem_566_18
Abstract: Background: Clinical trials have shown promising results in terms of glycemic control and weight reduction with the use of sodium glucose co-transporter 2 inhibitors (SGLT2i) in type 2 diabetes mellitus (T2DM). However, real-world evidence from…
read more here.
Keywords:
transporter inhibitors;
world;
glucose transporter;
sodium glucose ... See more keywords